| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATNX | Athenex, Inc. | Spiegel Robert J. | Director | Apr 21, 2023 | Option Exercise | $1.30 | 2,300 | 3,001 | 4,592 | Apr 24, 2023, 04:45 PM | |
| ATNX | Athenex, Inc. | Spiegel Robert J. | Director | Jan 13, 2023 | Option Exercise | $0.19 | 16,130 | 3,000 | 45,830 | Jan 17, 2023, 08:19 AM | |
| ATNX | Athenex, Inc. | Spiegel Robert J. | Director | Oct 07, 2022 | Option Exercise | $0.24 | 12,453 | 3,000 | 29,700 | Oct 12, 2022, 08:34 AM | |
| ATNX | Athenex, Inc. | Spiegel Robert J. | Director | Jul 20, 2022 | Option Exercise | $0.67 | 4,508 | 3,000 | 8,497 | Jul 21, 2022, 05:05 PM | |
| ATNX | Athenex, Inc. | Spiegel Robert J. | Director | Apr 08, 2022 | Option Exercise | $0.75 | 3,989 | 3,000 | 3,989 | Apr 11, 2022, 06:56 PM | |
| GERN | GERON CORP | Spiegel Robert J. | Director | Sep 13, 2018 | Option Exercise | $2.95 | 175,000 | 516,550 | 110,576 | Sep 13, 2018, 09:28 PM | |
| GERN | GERON CORP | Spiegel Robert J. | Director | Sep 13, 2018 | Sale | $6.85 | 175,000 | 1,198,750 | 65,576 | Sep 13, 2018, 09:28 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Spiegel Robert J. | Director | Feb 13, 2018 | Option Exercise | $18.00 | 5,130 | 92,340 | 0 | Feb 13, 2018, 04:57 PM | |
| EDGE | Edge Therapeutics, Inc. | Spiegel Robert J. | Director | Oct 06, 2015 | Option Exercise | $7.91 | 1,549 | 12,253 | 38,661 | Oct 08, 2015, 04:14 PM | |
| EDGE | Edge Therapeutics, Inc. | Spiegel Robert J. | Director | Oct 06, 2015 | Buy | $11.00 | 3,000 | 33,000 | 37,112 | Oct 08, 2015, 04:14 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Spiegel Robert J. | Chief Medical Officer | Mar 13, 2015 | Sale | $75.10 | 1,030 | 77,355 | 3,241 | Mar 13, 2015, 06:03 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Spiegel Robert J. | Chief Medical Officer | Mar 13, 2014 | Sale | $31.75 | 1,186 | 37,656 | 4,269 | Mar 14, 2014, 05:48 PM |
Menu